Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

Patrick Marcellin; Qing Xie; Seung Woon Paik; Robert Flisiak; Teerha Piratvisuth; J?rg Petersen; Tarik Asselah; Markus Cornberg; Denis Ouzan; Graham R. Foster; Georgios Papatheodoridis; Diethelm Messinger; Loredana Regep; Georgios Bakalos; Ulrich Alshuth; Pietro Lampertico; Heiner Wedemeyer

首页> 外文期刊>PLoS One >Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

【24h】

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

机译：慢性乙型肝炎患者Peginterferon Alfa-2a国际观察S级研究的最终分析

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and aims Sustained off-treatment immune control is achievable in a proportion of patients with chronic hepatitis B treated with peginterferon alfa-2a. We evaluated on-treatment predictors of hepatitis B surface antigen (HBsAg) clearance 3 years after peginterferon alfa-2a treatment and determined the incidence of hepatocellular carcinoma.

机译：背景和目标是持续的脱离治疗免疫控制是可实现的，其患有Peginterferon Alfa-2a处理的慢性乙型肝炎患者的比例可实现。我们评估了Peginterferon Alfa-2a-2a治疗后3年的乙型肝炎表面抗原（HBsAg）间隙的治疗预测因子，并确定了肝细胞癌的发生率。

著录项

来源
《PLoS One》 |2020年第4期|共16页
作者
Patrick Marcellin; Qing Xie; Seung Woon Paik; Robert Flisiak; Teerha Piratvisuth; J?rg Petersen; Tarik Asselah; Markus Cornberg; Denis Ouzan; Graham R. Foster; Georgios Papatheodoridis; Diethelm Messinger; Loredana Regep; Georgios Bakalos; Ulrich Alshuth; Pietro Lampertico; Heiner Wedemeyer;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词
入库时间 2022-08-19 02:52:28

相似文献

外文文献
中文文献
专利

1. Simple Predictive Model for Identifying Patients with Chronic Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High Probability of Sustained Virologic Response with Peginterferon Alfa-2a/Ribavirin: Pooled Analysis of Data from Two Large, International Cohort Studies [J] . Asselah Tarik, Esmat Gamal, Sanai Faisal M., Advances in therapy. . 2016,第10期

机译：鉴定慢性丙型肝炎和丙型肝炎病毒基因型4感染并具有持续病毒学应答的高可能性的患者的简单预测模型，用聚乙二醇干扰素Alfa-2a /利巴韦林治疗：来自两项大型国际研究的数据汇总分析
2. Outcomes of chronic hepatitis C therapy in patients treated in community versus academic centres in Canada: final results of APPROACH (a prospective study of peginterferon alfa-2a and ribavirin at academic and community centres in Canada). [J] . Myers RP, Cooper C, Sherman M, Canadian journal of gastroenterology . 2011,第9期

机译：在加拿大社区与学术中心接受治疗的患者进行慢性丙型肝炎治疗的结果：方法的最终结果（加拿大学术和社区中心对聚乙二醇干扰素α-2a和利巴韦林的前瞻性研究）。
3. Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) [J] . Myers Robert P, Cooper Curtis, Sherman Morris, ISRN Hypertension . 2011,第9期

机译：在加拿大社区对学术中心接受治疗的患者中进行慢性丙型肝炎治疗的结果：方法的最终结果（加拿大学术和社区中心对Peginterferon alfa-2a和Ribavirin的前瞻性研究）
4. HCV-related Factors but not HIV-Related Factors at Baseline Predict the Response to Treatment With Peginterferon alfa-2a (40KD) (PEGASYS) Plus Ribavirin (COPEGUS) in Patients With HCV/HIV Co-infection: Predictor Analysis From the APRICOT Study [C] . D. Cooper, F.J. Torriani, M. Rodriguez Torres International AIDS Conference . 2004

机译：HCV相关因素但基线上没有艾滋病毒相关因素预测与HCV / HIV共感染患者的Peginterferon Alfa-2a（40kd）（Pegasys）（Pegasys）加利巴韦林（Copegus）对治疗的反应：来自杏研究的预测因素分析
5. Incidence, Durability, and Clinical Outcomes of Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B [D] . Yip, Cheuk Fung. 2019

机译：慢性乙型肝炎患者乙型肝炎表面抗原血管疮的发病率，耐久性和临床结果
6. Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B [O] . Patrick Marcellin, Qing Xie, Seung Woon Paik, 2020

机译：慢性乙型肝炎患者Peginterferon Alfa-2a的国际观察S-Collate研究的最终分析
7. PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting [O] . Areias J., Branco T., Calinas F., 2011

机译：PGI18治疗Peginterferon Alfa-2a或Peginterferon Alfa-2b的慢性丙型肝炎患者：葡萄牙NHS机构的成本-效果分析

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

摘要

著录项

相似文献

相关主题

期刊订阅